Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RARE

Ultragenyx Pharmaceutical Inc.

CIK 0001515673 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$25.83
↑ 0.51 (2.01%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership

Key stats

Market Cap
$2.55B
P/E Ratio
-4.35
EPS
-5.83
Dividend Yield
Not covered
52W Position
35%
Beta
1.40

Valuation multiples

Fwd P/E
Not covered
PEG
-0.24
P/B
-8.75
P/S
3.55
EV/Revenue
3.38
ROE
201.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 35%
$18.29$39.89

Latest Financials

2025-12-31 FY
Revenue
$673.00M
Net Income
-$575.00M
Total Assets
$1.53B
Free Cash Flow
-$472.00M

Recent news